Graves’ Disease in 100 Cases in Conakry: Epidemiological, Clinical, Therapeutic, and Evolutionary Aspects

Context and Objective: Graves' disease is an autoimmune disorder of the thyroid gland that occurs in genetically predisposed individuals.It represents the most frequent cause of hyperthyroidism with a clear female predominance.The objective of our work was to report the sociodemographic, clinical, therapeutic, and evolutionary characteristics of Graves' disease at the University Hospital of Conakry.Methods: This was a cross-sectional, descriptive study, over the period from December 2016 to June 2021, at the endocrinology consultation of Donka University Hospital.Epidemiological, clinical, therapeutic, and evolutionary variables of patients followed up for Graves' disease were collected and analyzed.The diagnosis of Graves' disease was based on the presence of clinical signs of thyrotoxicosis, diffuse goiter, exophthalmos, and or T-RAK positivity.Results: Graves' disease was related to 33% of thyroid consultations and 64% of hyperthyroidism.The sex ratio M/F was 0.07.The median age of the patients was 39.4 ± 13 years.The main reason for consultation was thyrotoxicosis syndrome, dominated by cardiovascular signs (92%).TRAK was performed in 38 patients with a positive result in 89%, i.e., a mean level of 17.93 mUI/l.All patients were treated with synthetic antithyroid drugs, with a favorable clinical evolution.Surgery was considered in 4 patients after the stabilization of the thyroid function.The follow-up was considered regular in 49 patients (49%).Conclusion: Graves' disease is the most frequent hyperthyroidism in Conakry with a clear predominance of women, especially young women.Efforts should be focused on improving diagnosis and the access to treatment for better patient compliance.